• Molecular NameDimercaprol
  • Synonym2,3-Dimercapro; 2,3-Dimercaptopropanol; BAL; British Anti-Lewisite
  • Weight124.228
  • Drugbank_IDN/A
  • ACS_NO59-52-9
  • Show 3D model
  • LogP (experiment)0.2
  • LogP (predicted, AB/LogP v2.0)0.6
  • pka8.6
  • LogD (pH=7, predicted)0.58
  • Solubility (experiment)86.9 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-0.79
  • LogSw (predicted, AB/LogsW2.0)28.62
  • Sw (mg/ml) (predicted, ACD/Labs)19.76
  • No.of HBond Donors1
  • No.of HBond Acceptors1
  • No.of Rotatable Bonds2
  • TPSA97.83
  • StatusN/A
  • AdministrationN/A
  • PharmacologyIt is used medically in treatment of arsenic, mercury, gold and lead, and other toxic metal poisoning.[4] In addition, it has in the past been used for the treatment of Wilson's disease, a genetic disorder in which the body tends to retain copper.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability0.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=0.85 (intraperitoneal)
  • LD50 (mouse)LD50=1.5 (intraperitoneal)